Cardio Diagnostics Holdings, Inc. (CDIO) — Financial statements
Income statement, balance sheet, and cash flow for Cardio Diagnostics Holdings, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.01↓57.5% | 0.03↑104.5% | 0.02↑1696.3% | 0.00↑5.4% | 0.00 | |
| Cost of Revenue | 0.40 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | -0.38↓1198.6% | 0.03↑104.5% | 0.02↑1696.3% | 0.00↑5.4% | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.64↑2101.6% | 0.03↓79.9% | 0.15↑258.9% | 0.04↑28.5% | 0.03 | |
| General & Administrative Expenses | 0.00↓100.0% | 8↑17.8% | 7↑57.6% | 4↑835.1% | 0.47 | |
| Selling & Marketing Expenses | 0.77↑320.3% | 0.18↑15.1% | 0.16↑71.0% | 0.09↓10.3% | 0.10 | |
| SG&A Expenses | 0.77↓90.8% | 8↑17.7% | 7↑57.9% | 4↑682.9% | 0.57 | |
| Other Expenses | 5↑23674.8% | 0.02↑2.9% | 0.02↑19.9% | 0.02↑0.0% | 0.02 | |
| Operating Expenses | 6↓27.4% | 8↑15.7% | 7↑59.6% | 5↑632.2% | 0.62 | |
| Total Costs & Expenses | 6↓22.6% | 8↑15.7% | 7↑59.6% | 5↑632.2% | 0.62 | |
| Operating Results | ||||||
| Operating Income | -6↑22.5% | -8↓15.5% | -7↓59.2% | -5↓633.1% | -0.62 | |
| Depreciation & Amortization | 0.40↑44.1% | 0.28↑147.6% | 0.11↑597.6% | 0.02↑0.0% | 0.02 | |
| EBITDA | -6↑24.8% | -8↓428.6% | -2↑67.1% | -5↓668.5% | -0.60 | |
| EBIT | -6↑22.5% | -8↓409.5% | -2↑64.8% | -5↓651.2% | -0.62 | |
| Interest & Other Income | ||||||
| Net Interest Income | -0.01↑19.8% | -0.02↑99.7% | -7 | 0.00 | 0.00 | |
| Interest Income | 0.00↓33.1% | 0.00↓0.4% | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.01↓20.6% | 0.02↓99.7% | 7 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00↑100.0% | -0.00↑100.0% | -6↓5076.8% | 0.11 | 0.00 | |
| Other Income / Expenses | -0.01↑19.8% | -0.02↑98.5% | -1↓908.0% | -0.11 | 0.00 | |
| Income Before Tax | -6↑22.5% | -8↓0.1% | -8↓79.7% | -5↓651.2% | -0.62 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -6↑22.5% | -8↓0.1% | -8↓79.7% | -5↓651.2% | -0.62 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -6↑22.5% | -8↓0.1% | -8↓79.7% | -5↓651.2% | -0.62 | |
| Bottom-Line Net Income | -6↑22.5% | -8↓0.1% | -8↓79.7% | -5↓651.2% | -0.62 | |
| EPS (Basic) | -3.71↑60.1% | -9.30↑53.0% | -19.80↑56.3% | -45.30↓2211.2% | -1.96 | |
| EPS (Diluted) | -3.71↑60.1% | -9.30↑53.0% | -19.80↑56.3% | -45.30↓2211.2% | -1.96 | |
| Weighted Average Shares | 2↓93.5% | 27↑6260.1% | 0.42↓86.3% | 3↑873.6% | 0.32 | |
| Weighted Average Diluted Shares | 2↓93.5% | 27↑6260.1% | 0.42↓86.3% | 3↑873.6% | 0.32 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.